Investor directory

Santé Ventures

Santé Ventures is a life sciences venture capital firm based in Austin, Texas, with an additional office in Boston, Massachusetts. Established in 2006, the firm focuses on early-stage investments in companies developing innovative medical technologies and healthcare delivery models. Santé Ventures targets seed to series B funding opportunities in the med-tech, biotechnology, and health tech sectors across the United States. The firm manages $281 million in capital through two funds and operates as a Registered Investment Adviser.
http://sante.com
http://www.santeventures.com
https://crunchbase.com/organization/sante-ventures
https://linkedin.com/company/sante-ventures
https://pitchbook.com/profiles/investor/11456-92
https://signal.nfx.com/firms/sante-ventures
https://twitter.com/santeventures
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=35542733
https://www.privateequityinternational.com/database/#/profile?id=11857

Auriel August

Principal

Louis Bock

Venture Partner

William E Cohn

Venture Partner

Joe Cunningham

Founding Managing Director

James Eadie

Managing Director

Douglas D. French

Managing Director

Michael Gutbrod

Senior Associate

Michael Gutbrod

Associate

Will Hooks

Analyst

David Kaufman

COO

Omar Khalil

Managing Director

Kevin M. Lalande

Co-Founder, Managing Director and Chief Investment Officer

Dennis McWilliams

Partner

Ashley Seehusen

CEO of Santé Accel and Venture Partner

Mitch Weaver

Analyst

Past deals in Minnesota

Cryosa

Series B in 2021
CryOSA, Inc., a medical device company, develops novel treatments for patients with sleep disordered breathing. It offers therapies for obstructive sleep apnea. CryOSA, Inc. was incorporated in 2014 and is based in Roseville, Minnesota.

Cryosa

Series A in 2020
CryOSA, Inc., a medical device company, develops novel treatments for patients with sleep disordered breathing. It offers therapies for obstructive sleep apnea. CryOSA, Inc. was incorporated in 2014 and is based in Roseville, Minnesota.

Endogenex

Series A in 2018
DyaMX is developing therapies for GI and metabolic disease processes.

Cryosa

Series A in 2018
CryOSA, Inc., a medical device company, develops novel treatments for patients with sleep disordered breathing. It offers therapies for obstructive sleep apnea. CryOSA, Inc. was incorporated in 2014 and is based in Roseville, Minnesota.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.